Keck Graduate Institute Featured in National Diabetes Film Series

The institute's work on type 2 diabetes remission is highlighted in a new digital documentary.

Mar. 30, 2026 at 9:09pm

An extreme close-up X-ray image revealing the intricate internal structures of a human pancreas, conceptually illustrating the medical focus of a documentary on type 2 diabetes treatment.A groundbreaking documentary shines a light on innovative approaches to managing and potentially reversing type 2 diabetes.Claremont Today

Keck Graduate Institute, a private graduate school in Claremont, California, has been featured in a new national digital film series focused on type 2 diabetes remission. The series explores innovative approaches to managing and potentially reversing the chronic condition.

Why it matters

The film series aims to raise awareness about emerging treatments and lifestyle interventions that can help those with type 2 diabetes achieve remission, reducing the long-term health risks associated with the disease. KGI's inclusion highlights its research and educational efforts in this important area of public health.

The details

The digital film series, produced by a national health organization, showcases KGI's work on developing new protocols and educational programs to support type 2 diabetes remission through lifestyle changes and targeted medical interventions. KGI has been at the forefront of exploring innovative approaches to managing this chronic condition.

  • The film series premiered on March 30, 2026.

The players

Keck Graduate Institute

A private graduate school in Claremont, California that is focused on health sciences education and research, including efforts to address type 2 diabetes.

Got photos? Submit your photos here. ›

What’s next

The film series is expected to be distributed widely through online platforms and community health organizations to educate the public about new developments in type 2 diabetes management.

The takeaway

KGI's inclusion in this national film series underscores its leadership in exploring solutions to the growing public health challenge of type 2 diabetes, which affects millions of Americans.